Press Release
May 27 2025
FORE Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
Read more
FORTE: A phase 2 Master Protocol Assessing Plixorafenib for BRAF-Altered Cancers
May 31, 2025 4:12 PM EDT
Read More
Press Release
May 22 2025
FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib
Read more
Press Release
Apr 30 2025
FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting
Read more